# US 2025/0082687 A1 · Composition for improving memory or cognitive ability, or preventing or treating brain neurological disease, comprising porcine brain enzyme hydrolysate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082687 A1
- Document ID: US20250082687A1
- Status: Published application
- Kind: A1
- Application number: 18/728,139
- Filed: 2023-01-09
- Published: 2025-03-13
- Earliest claimed: 2022-01-11
- Assignees: Unimed Pharmaceuticals, LLC
- Applicants: Unimed Pharmaceuticals Inc.
- Inventors: Keun-Nam KIM; Jae-Joon SHIN; Kyung-Min KIM; Min-Ju KIM; Yun-Mi HWANG; Sun-Myung YOON; Dae-Eun KIM; Jin-Wook YANG; Gun-Won BAE
- Web page: https://patentgrep.com/patent/US20250082687A1

## CPC

- A23L 33/18: Peptides; Protein hydrolysates
- A61K 35/30: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A61K 38/012: {from animals}
- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a composition for improving memory, improving cognition, preventing or treating cerebral neurological disease, comprising porcine brain enzyme hydrolysate. The composition can exhibit neuroprotective activity, brain-derived neurotrophic factor (BDNF) production activity, acetylcholinesterase inhibitory activity and reactive oxygen species (ROS) inhibitory activity.

## Claims

### Claim 1

A food composition for improving memory, improving cognitive function, or preventing or improving cerebral neurological disease, comprising a porcine brain enzyme hydrolysate comprising at least one of the peptides consisting of SEQ ID NO: 1 or SEQ ID NO: 2 as an active ingredient.

### Claim 2 (depends on 1)

The food composition of claim 1 wherein the porcine brain enzyme hydrolysate is hydrolyzed by one or more proteolytic enzymes.

### Claim 3 (depends on 1)

The food composition of claim 1 wherein the peptide is derived from porcine brain hydrolysate.

### Claim 4 (depends on 1)

The food composition of claim 1 wherein the porcine brain enzyme hydrolysate exhibits neuroprotective activity and brain-derived neurotrophic factor (BDNF) production activity.

### Claim 5 (depends on 1)

The food composition of claim 1 wherein the porcine brain enzyme hydrolysate exhibits acetylcholinesterase inhibitory activity and reactive oxygen species (ROS) inhibitory activity.

### Claim 6 (depends on 1)

The food composition of claim 1 wherein the cerebral neurological disease is selected from the group consisting of Alzheimer's Disease, Mild Cognitive Impairment, Senile Dementia, Parkinson's Disease, Huntington's Disease, Lewy Body Dementia, Frontotemporal Dementia, cerebral infarction, stroke, and epilepsy.

### Claim 7 (depends on 1)

The food composition of claim 1 wherein the composition is formulated in a dosage form selected from the group consisting of tablet, capsule, powder, granule, liquids, and pill.

### Claim 8

A method for improving memory, improving cognitive function, or preventing or treating cerebral neurological disease, the method comprising administering a pharmaceutical composition comprising a porcine brain enzyme hydrolysate comprising at least one of the peptides consisting of SEQ ID NO: 1 or SEQ ID NO: 2 as an active ingredient to a subject in need thereof.

### Claim at position 9

9-14. (canceled)

### Claim 15

Porcine brain enzyme hydrolysate comprising at least one of the peptides consisting of SEQ ID NO: 1 or SEQ ID NO: 2.

### Claim 16 (depends on 15)

The porcine brain enzyme hydrolysate of claim 15, wherein the peptide is purified or chemically synthesized from a pig brain enzyme hydrolysate.

### Claim 17 (depends on 15)

The porcine brain enzyme hydrolysate of claim 15, wherein the peptide is used to improve memory, improve cognitive ability, or prevent or treat cerebral neurological disease.

### Claim 18 (depends on 17)

The porcine brain enzyme hydrolysate of claim 17, wherein the cerebral neurological disease is selected from the group consisting of Alzheimer's Disease, Mild Cognitive Impairment, Senile Dementia, Parkinson's Disease, Huntington's Disease, Lewy Body Dementia, Frontotemporal Dementia cerebral infarction, stroke, and stroke.

### Claim at position 14

-20. (canceled)

### Claim 21

Peptide of SEQ ID NO: 1 or SEQ ID NO: 2.

### Claim 22 (depends on 21)

The peptide of claim 21, wherein the peptide is purified from porcine brain enzyme hydrolysate or chemically synthesized.

### Claim 23

(canceled)

### Claim 24 (depends on 21)

The peptide of claim 21, wherein the peptide is used to improve memory, improve cognition, or prevent or treat cerebral neurological disease.

### Claim 25 (depends on 23)

The peptide of claim 23, wherein the cerebral neurological disease is selected from the group consisting of Alzheimer's Disease, Mild Cognitive Impairment, Senile Dementia, Parkinson's Disease, Huntington's Disease, Lewy Body Dementia, Frontotemporal Dementia cerebral infarction, stroke, and epilepsy.

### Claim at position 20

26-29. (canceled)
